Evelyn Bergendal - UCB SA Insider

UCB SA -- USA Stock  

USD 35.12  0.005  0.01%

Non-Executive Vice Chairwoman of the Board

Mrs. Evelyn Diego du Monceau de Bergendal was appointed NonExecutive Chairman of the Board of UCB S.A. with effect from April 27, 2017. Prior to that, she has served as NonExecutive Vice Chairwoman of the Board of the Company since June 13, 2006. Between 1984 and June 13, 2006, she served as NonExecutive Director of the Company. She also is Chair of the Governance, Nomination and Compensation Committee since 2006. She graduated in Applied Economics from Universite catholique de Louvain in Belgium in 1972. She followed courses in International Relations at the Kennedy School of Harvard University and in Soil Science, Animal Science and Zoology at the Agricultural and Technical College of Farmingdale . She was Member of the Board of Directors of Financiere de Tubize and member of the Board of Solvay S.A. She has acted as Member of the Nomination and of the Remuneration Committees of Solvay S.A.
Age: 66  Executive Since 2017      
32 2 559 99 99  http://www.ucb-group.com

Management Efficiency

The company has return on total asset (ROA) of 5.76 % which means that it generated profit of $5.76 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.02 % meaning that it generated $13.02 on every $100 dollars invested by stockholders.
The company has accumulated 1.9 B in total debt with debt to equity ratio (D/E) of 28.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. UCB SA has Current Ratio of 1.09 suggesting that it may not have the ability to pay its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Rebecca LimWestpac Banking Corporation
2016
Alexandra HolcombWestpac Banking Corporation
2014
Keith WeedUnilever N V
2010
Loeki PuteraPT Chandra Asri Petrochemical T
2011
Dave BComWestpac Banking Corporation
N/A
Christine ParkerWestpac Banking Corporation
2011
Ritva SotamaaUnilever N V
2013
Ek TanPT Chandra Asri Petrochemical T
2011
David BlanchardUnilever N V
2013
David LindbergWestpac Banking Corporation
2015
Chaovalit EkabutPT Chandra Asri Petrochemical T
2012
Tonia LovellUnilever N V
2010
Gary ThursbyWestpac Banking Corporation
2016
Marc EngelUnilever N V
2016
Agus PangestuPT Chandra Asri Petrochemical T
2011
Takashi AmejimaNippon Telegraph and Telephone
2017
Loeki PutraPT Chandra Asri Petrochemical T
2008
Hon HoPT Chandra Asri Petrochemical T
2015
Leena NairUnilever N V
2016
David CurranWestpac Banking Corporation
2014
Douglas BaillieUnilever N V
2011

Entity Summary

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system. UCB SA (UCBJY) is traded on OTC Market in USA. It is located in Allée de la Recherche, Brussels, and employs 7,643 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add UCB SA to your portfolio

Top Management

UCB SA Leadership Team
Pascale Richetta, President
Detlef Thielgen, CFO
Kay Davies, Director
Anna Richo, EVP
Gerhard Mayr, Chairman
Cyril Janssen, Director
Cedric Rijckevorsel, Director, CFA
JeanChristophe Tellier, Chairman
Arnoud Calesberg, Director
Mark McDade, COO
Xavier Michel, President
Bharat Tewarie, President, MBA
Roch Doliveux, Chairman, Ph.D
Norman Ornstein, Director
Jeff Wren, President
JeanPierre Kinet, Director, Ph.D
Antje Witte, VP
Alice Dautry, Director
Harriet Edelman, Director, MBA
Ulf Wiinberg, Director
Thomas McKillop, Director, Ph.D
Charl Zyl, President
Fabrice Enderlin, President
Pierre Gurdjian, Director
Ismail Kola, EVP, Ph.D
Emmanuel Caeymaex, President
Evelyn Bergendal, Executive
Iris LoewFriedrich, President, Ph.D
CharlesAntoine Janssen, Director
Albrecht Graeve, Director

Stock Performance

UCB SA Performance Indicators